18TH EUROPEAN CONGRESS ON BIOTECHNOLOGY
The International Conference Centre GenevaGENEVA, SWITZERLAND Visit the Venue to read more
The first European Congress of Biotechnology in Interlaken, Switzerland, in 1978 marked the inauguration of the European Federation of Biotechnology (EFB). In 2018, we are delighted to welcome you back to Switzerland to celebrate the 40th anniversary of the longest running biotechnology congress in Europe. Between Lake Geneva and surrounding mountains, ECB2018 will be held in the beautiful and vibrant city of Geneva.
EFB began as a rather small group of working parties from different European countries. Their interests ranged from fermentation technology to the public perception of biotechnology, applied microbiology and genetics, downstream processing and measurement and control. Forty years later, EFB is now open to all who share our mission of promoting the safe, sustainable and ethical use of biological systems for the benefit of mankind. The current 30,000 personal members, who span the world from Latin America to China, Korea and Japan, is also a reflection of the success of recent EFB congresses.
Interests today are now much wider, spanning green, red and white biotechnologies. Key member activities focus on plant, food, agriculture and environmental biotechnology on the green side, and biopharmaceuticals, healthcare, pathogenicity and antibiotic resistance on the red. Physiology and genomics of microorganisms impact many aspects of biotechnology, while white topics include biomaterials, bioengineering/bioprocessing, and both systems and synthetic biology.
Join us in Geneva in July 2018 to present your most recent work as part of EFB as the Voice of Biotechnology in Europe.
Prof. Gerrit Borchard
Chair of Scientific Committee
OPENING PLENARY LECTURER, SUNDAY 1 JULY 2018,
Kurt Wüthrich is the Cecil H. and Ida M. Green Professor of Structural Biology at The Scripps Research Institute, La Jolla, CA, USA, and a Professor of Biophysics at the ETH Zürich, Zürich, Switzerland. His research interests are in structural biology and structural genomics. His specialty is nuclear magnetic resonance (NMR) spectroscopy with biological macromolecules, where he contributed the NMR method of three-dimensional structure determination of proteins and nucleic acids in solution. Kurt Wüthrich’s achievements have been recognized by the Prix Louis Jeantet de Médecine, the Kyoto Prize in Advanced Technology, the Nobel Prize in Chemistry, and by a number of other awards and honorary degrees.
Dario Neri earned a PhD in Chemistry at the Swiss Federal Institute of Technology (ETH Zürich) and performed post-doctoral research at the Medical Research Council Centre in Cambridge (UK). He has now been a Professor at the ETH Zürich since 1996. The research of the group Neri focuses on the engineering of therapeutic antibodies for the therapy of cancer and other angiogenesis-related disorders. Other research activities include the chemical proteomic discovery of novel vascular markers of pathology and the development of DNA-encoded chemical libraries. Dario Neri is a co-founder of Philogen (www.philogen.com), a Swiss-Italian biotech company which has brought five antibody-based products into multicenter clinical trials for the treatment of cancer and of rheumatoid arthritis.
Rainer Meckenstock did his PhD in Biochemistry at the ETH Zürich, Switzerland (1993). He then did a Postdoc at EAWAG, Dübendorf, Switzerland, where he developed molecular tools to detect microbial biodegradation processes in the environment. In 1996 he became senior researcher at University of Konstanz, Germany where he worked on microbial ecology of groundwater and anaerobic degradation of polycyclic aromatic hydrocarbons. He then joined the University of Tübingen, Germany where he continued to work on microbiology of groundwater, anaerobic degradation of polycyclic aromatic hydrocarbons (PAH) and stable isotope fractionation to assess biodegradation. From 2003 – 2014 he was director of the Institute for Groundwater Ecology at the Helmholtz Center München Munich, Germany. Since 2014, he is Professor at the University of Duisburg-Essen, Germany where he studies how environmental contaminants are degraded in the environment and how technical solutions can overcome limitations.
KRISTALA JONES PRATHER
Kristala Jones Prather is the Arthur D. Little Professor of Chemical Engineering at MIT. She received an S.B. degree from MIT in 1994 and Ph.D. from the University of California, Berkeley (1999), and worked 4 years in BioProcess Research and Development at the Merck Research Labs prior to joining the faculty of MIT. Her research interests are centered on the design and assembly of recombinant microorganisms for the production of small molecules. Prather is the recipient of an Office of Naval Research Young Investigator Award (2005), a Technology Review “TR35” Young Innovator Award (2007), a National Science Foundation CAREER Award (2010), the Biochemical Engineering Journal Young Investigator Award (2011), and the Charles Thom Award of the Society for Industrial Microbiology and Biotechnology (2017). Additional honors include selection as the Van Ness Lecturer at Rensselaer Polytechnic Institute (2012), and as a Fellow of the Radcliffe Institute for Advanced Study (2014-2015).
Twan Lammers obtained a D.Sc. degree in Radiation Oncology from Heidelberg University in 2008 and a Ph.D. degree in Pharmaceutics from Utrecht University in 2009. In the same year, he started the Nanomedicine and Theranostics group at the Institute for Experimental Molecular Imaging at RWTH Aachen University Clinic. In 2014, he was promoted to full professor at the faculty of medicine at RWTH Aachen. He has published over 150 research articles and reviews (h-index 46), and has received several awards. He is associate editor for Europe for the Journal of Controlled Release, and serves on the editorial board member of several other journals. His primary research interests include drug targeting to tumors, image-guided drug delivery and tumor-targeted combination therapies.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Scientists from academia and industry are invited to submit abstracts for oral and poster presentations describing original research in any of the conference scientific topics. The scientific committee will select the type of contribution (oral or posters) based on the review of abstracts.
Guidelines And Instructions:
Please note that you will need to create an account in order to submit your abstract.
Please ensure that you follow the rules below when submitting your abstract:
The title of the abstract must be less than 20 words. Please do not use block capital letters or capital letters except for the first word or names.
The body of the abstract must be concise with less than 250 words. The abstract system will not accept abstracts that exceed 250 words (body of the abstract).
Please underline the name of the presenting author on the abstract. If the submitting author is also the presenting author then please mark this as the presenting author. If the submitting author is different please indicate both the submitting author and the presenting author.
Standard abbreviations and SI units must be used. Non-standard abbreviations must be defined in full at their first appearance.
Abstracts must not contain any images or tables.
Careful typing and proofreading are essential, as otherwise the abstract may be amended or rejected.
The submission system allows submitters to save and continue to work on the abstract later (by clicking on “Save as draft”). If you choose this option you can log in and continue to work on the abstract at any point up to the abstract deadline. Please ensure that you have selected “submission” when you have completed the abstract and no further work is necessary.
Please note that all abstract presenters are required to register for the conference. Please ensure that they have registered and paid their registration fee no later than 5 May 2018. If you have not registered by this date your abstract will be withdrawn.
Abstract submission deadline 2018-03-03
The European Federation of Biotechnology prides itself in providing a platform for industry and academia to meet.
The Congress provides a number of opportunities for companies to network with the leading European biotechnologists and:
Sponsor the meeting or individual symposia
Take part in discussions and networking
Exhibit at the trade exhibition
Sponsorship & Exhibition Opportunities at a Glance.
Please ensure you contact us as soon as possible to secure a prime position stand in the exhibition hall.
For further information or to book a place please contact Ashley Webb by calling: +39 344 233 1622 or emailing: email@example.com
Congress Team , TFI Group